Review

ccn4 duoset elisa kit (R&D Systems)

R&D Systems is a verified supplier

R&D Systems manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

R&D Systems ccn4 duoset elisa kit
Figure 1. <t>CCN4</t> is associated with reduced overall survival of patients diagnosed with primary melanoma and a shift in immune contexture.

Figure 1. <t>CCN4</t> is associated with reduced overall survival of patients diagnosed with primary melanoma and a shift in immune contexture.

Ccn4 Duoset Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ccn4+duoset+elisa+kit/Mouse%2FRat+WISP-1%2FCCN4+DuoSet+ELISA/pm35099839-339-9-13
Average 90 stars, based on 1 article reviews

ccn4 duoset elisa kit - by Bioz Stars, 2026-09

90/100 stars

Images

1) Product Images from "Cell Communication Network factor 4 promotes tumor-induced immunosuppression in melanoma."

Article Title: Cell Communication Network factor 4 promotes tumor-induced immunosuppression in melanoma.

Journal: EMBO reports

doi: 10.15252/embr.202154127

Figure 1. CCN4 is associated with reduced overall survival of patients diagnosed with primary melanoma and a shift in immune contexture.

Figure Legend Snippet: Figure 1. CCN4 is associated with reduced overall survival of patients diagnosed with primary melanoma and a shift in immune contexture.

Techniques Used:

Figure Legend Snippet: Figure 3. CCN4 knockout increased CTL and NK effector cells and decreased MDSC in the tumor microenvironment.

Techniques Used: Knock-Out

Figure 5. Knockout of CCN4 down-regulated CCL2 and CXCL1 expression and decreased glycolysis and glycolytic capacity in YUMM1.7 melanoma cells.

Figure Legend Snippet: Figure 5. Knockout of CCN4 down-regulated CCL2 and CXCL1 expression and decreased glycolysis and glycolytic capacity in YUMM1.7 melanoma cells.

Techniques Used: Knock-Out, Expressing

Figure Legend Snippet: Figure 7. CCN4 knockout further promoted the anti-tumor effect of immune checkpoint blockade therapy.

Techniques Used: Knock-Out

Enzyme-linked Immunosorbent Assay:

Article Title: Cell Communication Network factor 4 promotes tumor-induced immunosuppression in melanoma.
Article Snippet: The cytokines, chemokines, and growth factors in TCM were detected with the Proteome Profiler Mouse XL Cytokine Array (R&D Systems, MN), following the manufacturer’s instructions. .. CCN4 was assayed in TCM using the mouse WISP-1/ CCN4 DuoSet ELISA Kit (R&D Systems). .. CCL2 and CXCL1 were also quantified with Mouse CCL2/JE/MCP-1 and Mouse CXCL1/KC DuoSet ELISA kits (R&D Systems), respectively.

Image Search Results

Journal: EMBO reports

Article Title: Cell Communication Network factor 4 promotes tumor-induced immunosuppression in melanoma.

doi: 10.15252/embr.202154127

Figure Lengend Snippet: Figure 1. CCN4 is associated with reduced overall survival of patients diagnosed with primary melanoma and a shift in immune contexture.

Article Snippet: CCN4 was assayed in TCM using the mouse WISP-1/ CCN4 DuoSet ELISA Kit (R&D Systems).

Techniques:

Journal: EMBO reports

Article Title: Cell Communication Network factor 4 promotes tumor-induced immunosuppression in melanoma.

doi: 10.15252/embr.202154127

Figure Lengend Snippet: Figure 3. CCN4 knockout increased CTL and NK effector cells and decreased MDSC in the tumor microenvironment.

Article Snippet: CCN4 was assayed in TCM using the mouse WISP-1/ CCN4 DuoSet ELISA Kit (R&D Systems).

Techniques: Knock-Out

Journal: EMBO reports

Article Title: Cell Communication Network factor 4 promotes tumor-induced immunosuppression in melanoma.

doi: 10.15252/embr.202154127

Figure Lengend Snippet: Figure 5. Knockout of CCN4 down-regulated CCL2 and CXCL1 expression and decreased glycolysis and glycolytic capacity in YUMM1.7 melanoma cells.

Article Snippet: CCN4 was assayed in TCM using the mouse WISP-1/ CCN4 DuoSet ELISA Kit (R&D Systems).

Techniques: Knock-Out, Expressing

Journal: EMBO reports

Article Title: Cell Communication Network factor 4 promotes tumor-induced immunosuppression in melanoma.

doi: 10.15252/embr.202154127

Figure Lengend Snippet: Figure 7. CCN4 knockout further promoted the anti-tumor effect of immune checkpoint blockade therapy.

Article Snippet: CCN4 was assayed in TCM using the mouse WISP-1/ CCN4 DuoSet ELISA Kit (R&D Systems).

Techniques: Knock-Out

Figure 2. WISP1 is secreted by tumor cells exposed to TGFb1 and triggers Col I linearization.

Journal: The EMBO journal

Article Title: The tumor cell-secreted matricellular protein WISP1 drives pro-metastatic collagen linearization.

doi: 10.15252/embj.2018101302

Figure Lengend Snippet: Figure 2. WISP1 is secreted by tumor cells exposed to TGFb1 and triggers Col I linearization.

Article Snippet: WISP1 ELISA WISP1 levels were detected in tissue culture-conditioned medium (24 h) with the Quantikine Mouse WISP1 ELISA Kit or with Human or Mouse WISP1 DuoSet ELISA Kit (R&D Systems).

Techniques:

Figure 5. High WISP1 gene expression levels correlate with poor prognosis in human cancers.

Journal: The EMBO journal

Article Title: The tumor cell-secreted matricellular protein WISP1 drives pro-metastatic collagen linearization.

doi: 10.15252/embj.2018101302

Figure Lengend Snippet: Figure 5. High WISP1 gene expression levels correlate with poor prognosis in human cancers.

Techniques: Gene Expression

Fig. 1. CCN4 increases VCAM-1 expression through αvβ5/α6β1 integrin receptor. (A) Synovial ﬂuid was obtained from normal (n=10) or osteoarthritis patients (n=15) and examined with ELISA for the expression of CCN4. (B) Human synovial ﬁbroblasts were cultured for 48 h, and media were collected to measure CCN4. (C–F) OASFs were incubated with various concentrations of CCN4 for 24 h or with CCN4 (30 ng/ml) for 6, 12, or 24 h. The mRNA, cell surface, and protein expression of VCAM-1 were examined by qPCR, ﬂow cytometry, and Western blotting. (G) OASFs were pretreated for 30 min with actinomycin D or cycloheximide followed by stimulation with CCN4 for 24 h, and VCAM-1 expression was examined by qPCR. (H–J) OASFs were pretreated for 30 min with α5β1, αvβ3, αvβ5, or α6β1 integrin antibody (3 μg/ml) followed by stimulation with CCN4 for 24 h, and VCAM-1 expression was examined by qPCR, ﬂow cytometry, and Western blotting. Results are expressed as the mean±S.E. *: pb0.05 as compared with basal level. #: pb0.05 as compared with CCN4-treated group.

Journal: Biochimica et biophysica acta

Article Title: CCN4 induces vascular cell adhesion molecule-1 expression in human synovial fibroblasts and promotes monocyte adhesion.

doi: 10.1016/j.bbamcr.2012.12.023

Figure Lengend Snippet: Fig. 1. CCN4 increases VCAM-1 expression through αvβ5/α6β1 integrin receptor. (A) Synovial ﬂuid was obtained from normal (n=10) or osteoarthritis patients (n=15) and examined with ELISA for the expression of CCN4. (B) Human synovial ﬁbroblasts were cultured for 48 h, and media were collected to measure CCN4. (C–F) OASFs were incubated with various concentrations of CCN4 for 24 h or with CCN4 (30 ng/ml) for 6, 12, or 24 h. The mRNA, cell surface, and protein expression of VCAM-1 were examined by qPCR, ﬂow cytometry, and Western blotting. (G) OASFs were pretreated for 30 min with actinomycin D or cycloheximide followed by stimulation with CCN4 for 24 h, and VCAM-1 expression was examined by qPCR. (H–J) OASFs were pretreated for 30 min with α5β1, αvβ3, αvβ5, or α6β1 integrin antibody (3 μg/ml) followed by stimulation with CCN4 for 24 h, and VCAM-1 expression was examined by qPCR, ﬂow cytometry, and Western blotting. Results are expressed as the mean±S.E. *: pb0.05 as compared with basal level. #: pb0.05 as compared with CCN4-treated group.

Article Snippet: Synovial fluid concentrations of CCN4 were measured with an enzyme-linked immunosorbent assay (ELISA), according to the protocol provided by the manufacturer (Human CCN4 ELISA kit; R&D Systems).

Techniques: Expressing, Enzyme-linked Immunosorbent Assay, Cell Culture, Incubation, Cytometry, Western Blot

Fig. 2. Syk is involved in CCN4-induced VCAM-1 expression. (A–C) OASFs were pretreated for 30 min with Syk inhibitor (10 μM) or transfected with Syk siRNA for 24 h followed by stimulation with CCN4 for 24 h, and VCAM-1 expression was examined by qPCR, ﬂow cytometry, and Western blotting. (D–G) OASFs were incubated with CCN4 for indicated time intervals or pretreated with αvβ5 or α6β1 mAb for 30 min before incubation with CCN4 for 15 min. The Syk phosphorylation and activity were determined by Western blotting and Syk kinase assay kit. Results are expressed as the mean±S.E. *: pb0.05 as compared with basal level. #: pb0.05 as compared with CCN4-treated group.

Journal: Biochimica et biophysica acta

Article Title: CCN4 induces vascular cell adhesion molecule-1 expression in human synovial fibroblasts and promotes monocyte adhesion.

doi: 10.1016/j.bbamcr.2012.12.023

Figure Lengend Snippet: Fig. 2. Syk is involved in CCN4-induced VCAM-1 expression. (A–C) OASFs were pretreated for 30 min with Syk inhibitor (10 μM) or transfected with Syk siRNA for 24 h followed by stimulation with CCN4 for 24 h, and VCAM-1 expression was examined by qPCR, ﬂow cytometry, and Western blotting. (D–G) OASFs were incubated with CCN4 for indicated time intervals or pretreated with αvβ5 or α6β1 mAb for 30 min before incubation with CCN4 for 15 min. The Syk phosphorylation and activity were determined by Western blotting and Syk kinase assay kit. Results are expressed as the mean±S.E. *: pb0.05 as compared with basal level. #: pb0.05 as compared with CCN4-treated group.

Techniques: Expressing, Transfection, Cytometry, Western Blot, Incubation, Phospho-proteomics, Activity Assay, Kinase Assay

Fig. 3. PKCδ is involved in CCN4-induced VCAM-1 expression in synovial ﬁbroblasts. (A–C) OASFs were pretreated for 30 min with GF109203X (3 μM), rottlerin (10 μM), and Ro320432 (10 μM) or transfected with PKCδ siRNA for 24 h followed stimulated with CCN4 for 24 h, and VCAM-1 expression was examined by qPCR, ﬂow cytometry, and Western blotting. OASFs were incubated with CCN4 for indicated time intervals (D) or pretreated with αvβ5 mAb, α6β1 mAb, or Syk inhibitor for 30 min before incubation with CCN4 for 15 min (E), and PKCδ phosphorylation was determined by Western blotting. Results are expressed as the mean±S.E. *: pb0.05 as compared with basal level. #: pb0.05 as com- pared with CCN4-treated group.

Journal: Biochimica et biophysica acta

Article Title: CCN4 induces vascular cell adhesion molecule-1 expression in human synovial fibroblasts and promotes monocyte adhesion.

doi: 10.1016/j.bbamcr.2012.12.023

Figure Lengend Snippet: Fig. 3. PKCδ is involved in CCN4-induced VCAM-1 expression in synovial ﬁbroblasts. (A–C) OASFs were pretreated for 30 min with GF109203X (3 μM), rottlerin (10 μM), and Ro320432 (10 μM) or transfected with PKCδ siRNA for 24 h followed stimulated with CCN4 for 24 h, and VCAM-1 expression was examined by qPCR, ﬂow cytometry, and Western blotting. OASFs were incubated with CCN4 for indicated time intervals (D) or pretreated with αvβ5 mAb, α6β1 mAb, or Syk inhibitor for 30 min before incubation with CCN4 for 15 min (E), and PKCδ phosphorylation was determined by Western blotting. Results are expressed as the mean±S.E. *: pb0.05 as compared with basal level. #: pb0.05 as com- pared with CCN4-treated group.

Techniques: Expressing, Transfection, Cytometry, Western Blot, Incubation, Phospho-proteomics

Fig. 4. JNK is involved in CCN4-induced VCAM-1 expression in synovial ﬁbroblasts. (A–C) OASFs were pretreated for 30 min with SP600125 (3 μM), SB203580 (10 μM), U0126 (10 μM), and PD98059 (10 μM) or transfected with JNK mutant for 24 h followed stimulated with CCN4 for 24 h, and VCAM-1 expression was examined by qPCR, ﬂow cytometry, and Western blotting. (D) OASFs were incubated with CCN4 for indicated time intervals, and ERK, p38, and JNK phosphorylation was determined by Western blotting. Results are expressed as the mean±S.E. *: pb0.05 as compared with basal level. #: pb0.05 as compared with CCN4-treated group.

Journal: Biochimica et biophysica acta

Article Title: CCN4 induces vascular cell adhesion molecule-1 expression in human synovial fibroblasts and promotes monocyte adhesion.

doi: 10.1016/j.bbamcr.2012.12.023

Figure Lengend Snippet: Fig. 4. JNK is involved in CCN4-induced VCAM-1 expression in synovial ﬁbroblasts. (A–C) OASFs were pretreated for 30 min with SP600125 (3 μM), SB203580 (10 μM), U0126 (10 μM), and PD98059 (10 μM) or transfected with JNK mutant for 24 h followed stimulated with CCN4 for 24 h, and VCAM-1 expression was examined by qPCR, ﬂow cytometry, and Western blotting. (D) OASFs were incubated with CCN4 for indicated time intervals, and ERK, p38, and JNK phosphorylation was determined by Western blotting. Results are expressed as the mean±S.E. *: pb0.05 as compared with basal level. #: pb0.05 as compared with CCN4-treated group.

Techniques: Expressing, Transfection, Mutagenesis, Cytometry, Western Blot, Incubation, Phospho-proteomics

Fig. 5. AP-1 is involved in the potentiation of VCAM-1 expression by CCN4. (A–C) OASFs were pretreated for 30 min with curcumin (3 μM) and tanshinone (5 μM) or transfected with c-Jun siRNA for 24 h then stimulated with CCN4 for 24 h, and VCAM-1 expression was examined by qPCR, ﬂow cytometry, and Western blotting. (D) OASFs were incubated with CCN4 for indicated time intervals, and c-Jun expression in cytosol and nucleus and c-Jun phosphorylation was determined by Western blotting. Results are expressed as the mean±S.E. *: pb0.05 as compared with basal level. #: pb0.05 as compared with CCN4-treated group.

Journal: Biochimica et biophysica acta

Article Title: CCN4 induces vascular cell adhesion molecule-1 expression in human synovial fibroblasts and promotes monocyte adhesion.

doi: 10.1016/j.bbamcr.2012.12.023

Figure Lengend Snippet: Fig. 5. AP-1 is involved in the potentiation of VCAM-1 expression by CCN4. (A–C) OASFs were pretreated for 30 min with curcumin (3 μM) and tanshinone (5 μM) or transfected with c-Jun siRNA for 24 h then stimulated with CCN4 for 24 h, and VCAM-1 expression was examined by qPCR, ﬂow cytometry, and Western blotting. (D) OASFs were incubated with CCN4 for indicated time intervals, and c-Jun expression in cytosol and nucleus and c-Jun phosphorylation was determined by Western blotting. Results are expressed as the mean±S.E. *: pb0.05 as compared with basal level. #: pb0.05 as compared with CCN4-treated group.

Techniques: Expressing, Transfection, Cytometry, Western Blot, Incubation, Phospho-proteomics

Fig. 6. CCN4 induced AP-1 activation through integrin/Syk/PKCδ and JNK pathways. (A) OASFs were pretreated with αvβ5 mAb, α6β1 mAb, Syk inhibitor, GF109203X, and rottlerin for 30 min then stimulated with CCN4 for 120 min, the chromatin immunoprecipitation assay was then performed. (B) OASFs were pretreated with Syk inhibitor, GF109203X, rottlerin, Ro320432, and SP600125 for 30 min then stimulated with CCN4 for 30 min, and p–c-Jun expression was determined by Western blotting. (C) OASFs were pretreated with Syk inhibitor, GF109203X, rottlerin, curcumin, and tanshinone for 30 min or transfected with Syk and PKCδ siRNA or JNK mutant before exposure to CCN4. AP-1 luciferase activity was measured, and the results were normalized to the β-galactosidase activity and expressed as the mean±S.E. for three independent experiments performed in triplicate. (D&E) OASFs were incubated with various concentrations of CCN4 for 24 h or transfected with VCAM-1 siRNA for 24 h then stimulated with CCN4 for 24 h. THP-1 cells labeled with BCECF-AM were added to OASFs for 6 h, and then the THP-1 cell adherence was measured by ﬂuorescence microscopy. Results are expressed as the mean±S.E. *: pb0.05 as com- pared with basal level. #: pb0.05 as compared with CCN4-treated group.

Journal: Biochimica et biophysica acta

Article Title: CCN4 induces vascular cell adhesion molecule-1 expression in human synovial fibroblasts and promotes monocyte adhesion.

doi: 10.1016/j.bbamcr.2012.12.023

Figure Lengend Snippet: Fig. 6. CCN4 induced AP-1 activation through integrin/Syk/PKCδ and JNK pathways. (A) OASFs were pretreated with αvβ5 mAb, α6β1 mAb, Syk inhibitor, GF109203X, and rottlerin for 30 min then stimulated with CCN4 for 120 min, the chromatin immunoprecipitation assay was then performed. (B) OASFs were pretreated with Syk inhibitor, GF109203X, rottlerin, Ro320432, and SP600125 for 30 min then stimulated with CCN4 for 30 min, and p–c-Jun expression was determined by Western blotting. (C) OASFs were pretreated with Syk inhibitor, GF109203X, rottlerin, curcumin, and tanshinone for 30 min or transfected with Syk and PKCδ siRNA or JNK mutant before exposure to CCN4. AP-1 luciferase activity was measured, and the results were normalized to the β-galactosidase activity and expressed as the mean±S.E. for three independent experiments performed in triplicate. (D&E) OASFs were incubated with various concentrations of CCN4 for 24 h or transfected with VCAM-1 siRNA for 24 h then stimulated with CCN4 for 24 h. THP-1 cells labeled with BCECF-AM were added to OASFs for 6 h, and then the THP-1 cell adherence was measured by ﬂuorescence microscopy. Results are expressed as the mean±S.E. *: pb0.05 as com- pared with basal level. #: pb0.05 as compared with CCN4-treated group.

Techniques: Activation Assay, Chromatin Immunoprecipitation, Expressing, Western Blot, Transfection, Mutagenesis, Luciferase, Activity Assay, Incubation, Labeling, Microscopy

Review

ccn4 duoset elisa kit (R&D Systems)

Structured Review

Images

1) Product Images from "Cell Communication Network factor 4 promotes tumor-induced immunosuppression in melanoma."

Related Articles

Enzyme-linked Immunosorbent Assay:

Similar Products

Image Search Results